Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brigitte C. Widemann, MD
National Cancer Institute (NCI)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uab Comprehensive Cancer Center
Birmingham, Alabama, United States
- Sarcoma Oncology Center
Santa Monica, California, United States
- Children'S Memorial Hospital - Chicago
Chicago, Illinois, United States
- Indiana University
Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Johns Hopkins
Baltimore, Maryland, United States
- Warren Grant Magnuson Clinical Center - Nci Clinical Trials Referral Office
Bethesda, Maryland, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Carolinas Hematology-Oncology Associates
Charlotte, North Carolina, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Pennsylvania Oncology Hematology Associates
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- M. D. Anderson Cancer Center at University of Texas
Houston, Texas, United States
- Huntsman Cancer Institute at University of Utah
Salt Lake City, Utah, United States
- Seattle Cancer Care Alliance at Washington University
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2005
- Primary completion
- 30 Jun 2014
- Completion
- 30 Jun 2014
- Last update posted
- 18 Sept 2018
- Registered enrollment
- 48
- Registry id
- NCT00304083
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.